Financial Performance - The company's operating revenue for Q3 2022 was ¥114,275,248.83, a decrease of 10.43% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2022 was ¥10,287,614.60, down 19.14% year-on-year[4] - The basic earnings per share for Q3 2022 was ¥0.1286, reflecting a decline of 39.35% compared to the previous year[4] - The company's net profit for the year-to-date was ¥51,860,012.84, reflecting a growth of 10.01% compared to the same period last year[4] - Total operating revenue for the third quarter of 2022 reached CNY 439,363,330.36, an increase of 12.0% compared to CNY 392,113,873.49 in the same period last year[19] - Net profit for the third quarter of 2022 was CNY 51,860,012.84, representing a growth of 9.0% from CNY 47,139,991.69 in the previous year[21] - The total comprehensive income for the third quarter was CNY 51,860,012.84, reflecting a growth of 9.0% compared to CNY 47,139,991.69 in the previous year[21] Assets and Liabilities - Total assets at the end of Q3 2022 reached ¥806,132,597.98, an increase of 63.32% from the end of the previous year[4] - Total assets increased to CNY 806,132,597.98, up from CNY 493,586,657.15, indicating a growth of 63.5% year-over-year[18] - The company's total liabilities amounted to CNY 150,867,537.92, a slight increase from CNY 148,501,447.78, reflecting a growth of 1.0%[18] - The equity attributable to shareholders of the parent company rose to CNY 655,265,060.06, up from CNY 345,085,209.37, marking an increase of 90.0%[18] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥70,792,488.66, up 106.39%[4] - Operating cash flow for the period reached ¥70,792,488.66, a significant increase of 106.5% compared to ¥34,299,939.03 in the previous period[22] - Total cash inflow from operating activities was ¥326,731,404.24, up from ¥221,026,050.44, reflecting a growth of 47.9%[22] - Cash outflow from operating activities increased to ¥255,938,915.58 from ¥186,726,111.41, representing a rise of 37.0%[22] - The company experienced a net increase in cash and cash equivalents of ¥311,018,984.32, compared to a decrease of ¥499,074.52 in the prior period[23] - The ending balance of cash and cash equivalents stood at ¥340,163,038.96, a substantial increase from ¥25,731,297.14 at the end of the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,286[11] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[11] - The total number of preferred shareholders is not applicable, indicating no preferred shares were issued[13] - The company has no shareholders participating in margin trading among the top ten shareholders[12] Expenses - The company’s sales expenses increased by 47.81% to ¥3,445,518.63, primarily due to new product EU registration fees[8] - The company’s financial expenses showed a dramatic increase of 1906.52%, resulting in a net financial income of -¥7,939,996.91[9] - Research and development expenses for the period were CNY 15,609,724.20, compared to CNY 14,008,075.86 in the previous year, showing an increase of 11.4%[19] - The total operating costs for the third quarter were CNY 385,614,359.99, an increase of 13.6% from CNY 339,558,672.31 in the previous year[19] - The company reported a decrease in income tax expenses to CNY 6,621,113.93 from CNY 8,695,638.78, a reduction of 23.9%[21] Investments - The company has invested in fixed assets totaling ¥96,290,762.92 as of September 30, 2022, compared to ¥92,291,598.79 at the beginning of the year[16] - The company has a long-term investment in construction projects amounting to ¥6,413,548.75, a significant increase from ¥658,407.08 at the beginning of the year[16] - The company’s investment cash outflow decreased by 44.62% to ¥36,000,000.00, attributed to reduced purchases of financial products[9] IPO and Share Issuance - The company issued 20 million shares in its public offering, which began trading on August 25, 2022[14] Audit Status - The report was not audited, indicating that the figures presented are preliminary and subject to change[24]
联合化学(301209) - 2022 Q3 - 季度财报